MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression
Yao Jiang(Anhui University of Science and Technology), Pengda Liu(University of North Carolina at Chapel Hill), Nikolay V. Dokholyan(University of Virginia), Ian J. Davis(Harvard University Press), Siyuan Su(Sericultural Research Institute), Gang Wu(University of Science and Technology of China), Charles M. Perou(University of North Carolina at Chapel Hill), Jiayi Qian(University of North Carolina at Chapel Hill), Eric Ubil(UNC Lineberger Comprehensive Cancer Center), Yang Xiang, William Y. Kim(University of North Carolina at Chapel Hill), Xiaodong Wang(University of North Carolina at Chapel Hill), Yanqiong Zhang(University of North Carolina at Chapel Hill), Konstantin I. Popov(University of North Carolina at Chapel Hill), Cheng Fan(University of North Carolina at Chapel Hill), Alisha Holtzhausen(Duke University), Janet Y. Leung(Bristol-Myers Squibb (Germany)), H. Shelton Earp(University of North Carolina at Chapel Hill)
Cited by 40
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k